ANNUAL REPORT[removed]HEALTH AND

First Page		Document Content
Date: 2012-05-31 05:34:49 Nutrition Lipids Treatment of bipolar disorder Essential nutrients Omega-3 fatty acid Docosahexaenoic acid Lovaza High-density lipoprotein Fish oil Fatty acids Chemistry Medicine		ANNUAL REPORT[removed]HEALTH AND Add to Reading List Source URL: www.pronova.com Download Document from Source Website File Size: 4,56 MB Share Document on Facebook

	Office of Nutritional Products Labeling and Dietary Supplements Division of Compliance and Enforcement Dietary Supplements Branch (HFS[removed]Food and Drug Administration 200 “C” St. S.W. Washington, D.C[removed] DocID: AwWz - View Document
	Vascular Medicine http://vmj.sagepub.com/ Polyunsaturated fatty acids and peripheral artery disease S Marlene Grenon, Millie Hughes-Fulford, Joseph Rapp and Michael S Conte Vasc Med[removed]: 51 DocID: zARP - View Document
	PRIOR AUTHORIZATION POLICY Omega-3 Fatty Acid Products omega-3-acid ethyl esters capsules (generic) Lovaza® (omega-3-acid ethyl esters capsules – GlaxoSmithKline) Vascepa® (icosapent ethyl capsules – Amarin) To Ini DocID: sIZC - View Document
	 LOVAZA may increase levels of LDL. Monitor LDL levels periodically during therapy. (5.1)  Use with caution in patients with known hypersensitivity to fish and/or DocID: kFXb - View Document
	DRAFT, DRAFT, DRAFT, DRAFT DocID: jnNx - View Document